Citadel Advisors’s Virax Biolabs VRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24.7K Buy
30,155
+16,616
+123% +$13.6K ﹤0.01% 5614
2025
Q1
$15.4K Buy
+13,539
New +$15.4K ﹤0.01% 5637
2024
Q2
Sell
-14,785
Closed -$10.6K 6884
2024
Q1
$10.6K Buy
+14,785
New +$10.6K ﹤0.01% 5674
2023
Q4
Sell
-1,636
Closed -$5.32K 6727
2023
Q3
$5.32K Buy
+1,636
New +$5.32K ﹤0.01% 5517